CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Articles
When & How to Use Changed Clinical Laboratory Consult Codes
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Liquid Biopsy Can Rule Out Need for Chemotherapy After Stage II Colon Cancer Surgery
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
How to Make Genetic Testing Relevant for All Groups
Researchers propose solutions to underrepresentation of certain groups in genetic databases, based on two recent initiatives.
New Guidelines Released for Pancreatic Cancer Screening
The American Society for Gastrointestinal Endoscopy releases new recommendations for screening those with genetic susceptibility.
Caris Life Sciences Settles Medicare 14-Day Rule Claims for $2.88 Million
The company was facing allegations that it had intentionally delayed submitting lab tests in order to circumvent the rule and receive payment.
Alleged Violation of Medicare’s 14-Day Rule Costs Company $2.8 Million
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
CMS Reschedules PAMA Reporting & Adds New PLA Codes
Here are the two key CLFS changes, set to take effect on July 1, 2022, that your billing staff needs to know about.
What the Federal COVID-19 Fraud Crackdown Means for Labs
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
Revised VALID Act Proposes Risk-Based FDA Regulation of LDTs
The most recent congressional effort to pass LDT legislation may prove to be the one that finally comes to fruition.
Beckman Coulter Tabs IDT to Distribute Its Biomek NGeniuS NGS System
IDT will distribute the automated Biomek NGeniuS instrument in the US, Canada, UK, Sweden, Germany, France, Austria, and the Netherlands.
New Partnership Aims to Improve Genomic Variant Interpretation
Agilent and Genomenon team up to bring users more effective software and search tools for making a genetic diagnosis.
BioMérieux Closes $416.8 Million Acquisition of Specific Diagnostics
Bringing the Specific Reveal Rapid AST system into the fold enhances French firm’s global position in clinical microbiology.
